Literature DB >> 25109632

γEpithelial Na(+) Channel (γENaC) and the Acid-Sensing Ion Channel 1 (ASIC1) expression in the urothelium of patients with neurogenic detrusor overactivity.

Chiara Traini1, Giulio Del Popolo2, Massimo Lazzeri3, Katia Mazzaferro1, Federico Nelli2, Laura Calosi1, Maria Giuliana Vannucchi1.   

Abstract

OBJECTIVE: To investigate the expression of two types of cation channels, γEpithelial Na(+) Channel (γENaC) and the Acid-Sensing Ion Channel 1 (ASIC1), in the urothelium of controls and in patients affected by neurogenic detrusor overactivity (NDO). In parallel, urodynamic parameters were collected and correlated to the immunohistochemical results. PATIENTS SUBJECTS AND METHODS: Four controls and 12 patients with a clinical diagnosis of NDO and suprasacral spinal cord lesion underwent urodynamic measurements and cystoscopy. Cold-cup biopsies were frozen and processed for immunohistochemistry and Western Blot. Spearman's correlation coefficient between morphological and urodynamic data was applied. One-way anova followed by Newman-Keuls multiple comparison post hoc test was applied for Western Blot results.
RESULTS: In the controls, γENaC and ASIC1 were expressed in the urothelium with differences in their cell distribution and intensity. In patients with NDO, both markers showed consistent changes either in cell distribution and labelling intensity compared with the controls. A significant correlation between a higher intensity of γENaC expression in the urothelium of patients with NDO and lower values of bladder compliance was detected.
CONCLUSIONS: The present findings show important changes in the expression of γENaC and ASIC1 in NDO human urothelium. Notably, while the changes in γENaC might impair the mechanosensory function of the urothelium, the increase of ASIC1 might represent an attempt to compensate for the excess in local sensitivity.
© 2014 The Authors BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cystoscopy; degenerin family; immunohistochemistry; spinal cord lesion; urodynamic parameters; western blot

Mesh:

Substances:

Year:  2015        PMID: 25109632     DOI: 10.1111/bju.12896

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

1.  Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.

Authors:  Daisuke Gotoh; Tetsuichi Saito; Sergei Karnup; Yosuke Morizawa; Shunta Hori; Yasushi Nakai; Makito Miyake; Kazumasa Torimoto; Kiyohide Fujimoto; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-11

2.  Adaptive changes of telocytes in the urinary bladder of patients affected by neurogenic detrusor overactivity.

Authors:  Chiara Traini; Maria-Simonetta Fausssone-Pellegrini; Daniele Guasti; Giulio Del Popolo; Jacopo Frizzi; Sergio Serni; Maria-Giuliana Vannucchi
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

Review 3.  Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?

Authors:  Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2022-07-18       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.